Analystreport

Intercept Pharmaceuticals Inc (NASDAQ: ICPT) was upgraded by analysts at Laidlaw from a "hold" rating to a "buy" rating.

Intercept Pharmaceuticals, Inc.  (ICPT) 
Last intercept pharmaceuticals, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.interceptpharma.com/investor-relations